Results 41 to 50 of about 33,645 (162)
Background: The use of amiodarone prior to cardiac transplant in adults is associated with worse post-transplant outcomes. Data are scarce in pediatrics regarding the association of pre-amiodarone use with post-transplant outcomes. We aim to describe and
Melodie M. Lynn, DO +15 more
doaj +1 more source
Background Amiodarone and warfarin are sometimes administered immediately after cardiac surgery. Although the interaction between long-term oral amiodarone and warfarin has been reported, the interaction between warfarin and short-term intravenous ...
Tomoki Takase +6 more
doaj +1 more source
Amiodarone is a commonly used antiarrhythmic agent but exhibits potential pulmonary toxicity. In this case series, we describe the clinical, radiographic, and histologic manifestations of three patients who developed interstitial lung disease (ILD ...
I‐Lin Tsai +4 more
doaj +1 more source
Neuroprotective effects of amiodarone in a mouse model of ischemic stroke
Background Ion channels play a crucial role in the development of ischemic brain injury. Recent studies have reported that the blockade of various types of ion channels improves outcomes in experimental stroke models.
Masakazu Kotoda +4 more
doaj +1 more source
Amiodarone pulmonary toxicity: a report on two cases
Amiodarone is an iodine-containing antiarrhythmic drug commonly used for the treatment of ventricular and supraventricular arrhythmias. Amiodarone toxicity has several clinical presentations and affects multiple organs. One well-known serious side effect
Ahmed Zedan +3 more
doaj
Mycobacterium tuberculosis (Mtb) as well as nontuberculous mycobacteria are intracellular pathogens whose treatment is extensive and increasingly impaired due to the rise of mycobacterial drug resistance.
Gül Kilinç +8 more
doaj +1 more source
.: Some class I antiarrhythmic drugs induce a sporadic hypoglycemia by producing insulin secretion via inhibition of ATP-sensitive K+ (KATP) channels of pancreatic β-cells.
Atsushi Nishida +5 more
doaj +1 more source
Intravenous amiodarone was approved in 1995 for the treatment of malignant and resistant ventricular arrhythmia. Although it is an "old drug," much has been learned recently about this complex drug and its application in a variety of cardiac arrhythmias.
Kowey, Peter R +3 more
openaire +2 more sources
: Objective To evaluate the efficacy and safety of Ding Xin Recipe (DXR) combined with amiodarone in patients with PVCs.Methods A total of 360 patients with PVCs across 7 centers in China were randomly assigned in a 1:1:1 ratio to receive up to 8 weeks ...
Feng-Hua Zhou +7 more
doaj +1 more source
Amiodarone is an antiarrhythmic agent used primarily to treat atrial and ventricular arrhythmias. However, the drug also has many adverse effects, including pulmonary toxicity, and a wide range of pulmonary diseases have been reported. Amiodarone-induced
Alexis LeVee +3 more
doaj +1 more source

